Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound veterinary preparation for treating poultry enteritis type colibacillosis

A technology for colibacillosis and avian enteritis, applied in the field of compound veterinary drug preparations, can solve problems such as decreased curative effect, achieve good therapeutic effect, prevent secondary infection, and be difficult to produce drug resistance.

Inactive Publication Date: 2014-02-05
QINGDAO AGRI UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to its extensive use, a certain degree of drug resistance has been produced, and the current curative effect has declined.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] 100g neomycin sulfate 12.75g (based on effective content) Lactate TMP 0.69g (based on effective content) Glutamine l 10g (based on effective content) glucose Add to 100g

[0012] Preparation method and steps: Grind and sieve each ingredient separately, accurately weigh according to the required ratio, mix for 25 minutes, semi-finished product quality inspection, subpackaging, packaging, and finished product quality inspection.

[0013] When in use, 100g of this preparation mixed with 10L of water is used to treat clinical poultry enteritis colibacillosis, with 4 consecutive days as a course of treatment, and the withdrawal period is 5 days.

[0014] The effective rate of this preparation in treating poultry enteritis colibacillosis is 62%, and the cure rate is 50%. Compared with 2.75% neomycin sulfate soluble powder, the effective rate and cure rate are respectively higher by 18% and 16%. ideal.

Embodiment 2

[0016] 100g neomycin sulfate 3g (based on effective content) Lactate TMP 0. 75g (based on effective content) Glutamine 10g (based on effective content) glucose Add to 100g

[0017] Preparation method and steps: Grind and sieve each ingredient separately, accurately weigh according to the required ratio, mix for 25 minutes, semi-finished product quality inspection, subpackaging, packaging, and finished product quality inspection.

[0018] When in use, 100g of this preparation mixed with 100L of water is used for the treatment of clinical poultry enteritis colibacillosis. Continuous use for 4 days is a course of treatment, and the drug withdrawal period is 5 days.

[0019] The effective rate and cure rate of this preparation in treating poultry enteritis colibacillosis are 82% and 71%, respectively. .

Embodiment 3

[0021] 100g neomycin sulfate 3. 25g (based on effective content) Lactic acid TMP 0. 8lg (based on effective content) Glutamine 10g (based on effective content) glucose Add to 100g

[0022] Preparation method and steps: crush and sieve each ingredient separately, accurately weigh according to the required ratio, mix for 25 minutes, semi-finished product quality inspection, sub-packaging, packaging, and finished product quality inspection.

[0023] When in use, mix 100g of this preparation with 100L of water for the treatment of clinical poultry enteritis colibacillosis, 4 consecutive days as a course of treatment, and the withdrawal period is 5 days.

[0024] The effective rate and curative rate of this preparation in treating poultry enteritis colibacillosis are 93%, 82% and 22% higher than 3.25% neomycin sulfate soluble powder, respectively. The curative effect is very ideal.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to a composition for treating poultry enteritis type colibacillosis in veterinary medicines. The preparation consists of the following components in percentage by weight: 3.25 percent of neomycin sulfate, 0.81 percent of lactate TMP (trimethoprim lactate), 10 percent of glutamine, and 85.94 percent of auxiliary glucose, wherein neomycin sulfate, lactate TMP and glutamine are main drug components. The veterinary composition is used for treating poultry enteritis type colibacillosis. The processing process of the composition comprises the following steps: respectively crushing and screening each component, and accurately weighing according to the required proportion; mixing for 25 minutes; inspecting a semifinished product; subpackaging, packaging and inspecting the finished product. According to the usage method, the composition is drunk in a ratio of 1 percent, and four days are taken as a course of treatment. The composition has a remarkable curative effect on poultry enteritis type colibacillosis, is low in drug tolerance, safe and low-toxic, and has good popularization and application values.

Description

technical field [0001] The invention relates to a compound veterinary drug preparation and a preparation process for treating poultry enteritis colibacillosis. Background technique [0002] Colibacillosis is one of the most common diseases in poultry farming, and enteritis colibacillosis is also one of the most serious diseases. In veterinary clinics, after poultry is infected with enteritis colibacillosis, it often manifests as diarrhea, loss of appetite, rough feathers, indigestion of feed, slow growth, gradual increase in elimination rate, and reduced production performance, causing serious damage to the poultry breeding industry. Economic losses. Moreover, after being infected with this disease, it will cause the poultry's resistance to decrease, and it is easy to develop secondary coccidiosis, etc., which will aggravate the disease, the treatment effect is not ideal, the mortality rate will increase, sometimes as high as 52%, and the economic loss will be more serious....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7036A61P31/04A61K31/505A61K31/198
Inventor 不公告发明人
Owner QINGDAO AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com